Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Carboni

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Pathology|July 1, 1992
Parathyroid glands in primary hyperparathyroidism: an ultrastructural morphometric study of 25 casesS Cinti, A Sbarbati, M Morroni, et al.
La Clinica Terapeutica|November 11, 2008
Efficacy of Bosentan in treatment of refractory sclerodermic bone prominences skin ulcersA G Richetta, C Mattozzi, E Maiani, et al.
Dermatology Online Journal|December 20, 2008
A case of infliximab-induced psoriasisA Richetta, C Mattozzi, V Carlomagno, et al.
La Clinica Terapeutica|June 15, 2007
PEL, Kaposi's sarcoma HHV8+ and idiopathic T-lymphocitopenia CD4+A Richetta, G F Amoruso, V Ascoli, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Pathology|July 1, 1992
Parathyroid glands in primary hyperparathyroidism: an ultrastructural morphometric study of 25 casesS Cinti, A Sbarbati, M Morroni, et al.
La Clinica Terapeutica|November 11, 2008
Efficacy of Bosentan in treatment of refractory sclerodermic bone prominences skin ulcersA G Richetta, C Mattozzi, E Maiani, et al.
Dermatology Online Journal|December 20, 2008
A case of infliximab-induced psoriasisA Richetta, C Mattozzi, V Carlomagno, et al.
La Clinica Terapeutica|June 15, 2007
PEL, Kaposi's sarcoma HHV8+ and idiopathic T-lymphocitopenia CD4+A Richetta, G F Amoruso, V Ascoli, et al.
Pageof 2